Coral Laboratories Ltd. | Small-cap | Healthcare
₹605.00
1.93%
| Coral Laboratories Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 1.2B
Gross Profit 619.9M 53.90%
Operating Income 242.3M 21.07%
Net Income 241.6M 21.00%

Balance Sheet Metrics

Total Assets 2.3B
Total Liabilities 282.6M
Shareholders Equity 2.0B
Debt to Equity 0.14

Cash Flow Metrics

Operating Cash Flow 106.4M
Free Cash Flow -41.7M

Revenue & Profitability Trend

Coral Laboratories Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 1.2B 821.0M 778.9M 732.2M 952.1M
Cost of Goods Sold 530.2M 403.4M 492.6M 426.4M 537.4M
Gross Profit 619.9M 417.5M 286.3M 305.8M 414.7M
Operating Expenses 210.1M 140.9M 114.5M 129.2M 164.0M
Operating Income 242.3M 142.6M 16.3M 62.2M 138.7M
Pre-tax Income 324.7M 207.3M 82.3M 118.6M 176.1M
Income Tax 83.1M 49.4M 17.8M 28.1M 40.6M
Net Income 241.6M 157.9M 64.5M 90.5M 135.5M
EPS (Diluted) - ₹44.19 ₹18.04 ₹25.32 ₹37.94

Income Statement Trend

Coral Laboratories Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 1.8B 1.5B 1.2B 1.3B 1.3B
Non-Current Assets 529.2M 518.3M 508.1M 590.9M 389.2M
Total Assets 2.3B 2.1B 1.7B 1.9B 1.7B
Liabilities
Current Liabilities 249.6M 249.0M 118.6M 255.2M 275.6M
Non-Current Liabilities 33.0M 32.8M 76.9M 83.3M 33.3M
Total Liabilities 282.6M 281.8M 195.5M 338.4M 309.0M
Equity
Total Shareholders Equity 2.0B 1.8B 1.5B 1.6B 1.4B

Balance Sheet Composition

Coral Laboratories Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 332.4M 209.0M 81.9M 109.0M 175.9M
Operating Cash Flow 106.4M -60.6M 174.1M 96.8M 16.5M
Investing Activities
Capital Expenditures -29.4M -9.9M -19.5M -55.5M -13.6M
Investing Cash Flow -52.7M -21.7M -46.2M -81.9M -22.5M
Financing Activities
Dividends Paid -7.1M - - - -
Financing Cash Flow -7.1M - - -1.0K 6.8M
Free Cash Flow -41.7M -64.6M 107.2M 5.4M -4.3M

Cash Flow Trend

Coral Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 8.59
Forward P/E 10.00
Price to Book 1.03
Price to Sales 1.81
PEG Ratio 10.00

Profitability Ratios

Profit Margin 21.00%
Operating Margin 7.74%
Return on Equity 12.76%
Return on Assets 6.96%

Financial Health

Current Ratio 7.07
Debt to Equity 1.77
Beta 0.81

Per Share Data

EPS (TTM) ₹67.62
Book Value per Share ₹562.96
Revenue per Share ₹321.89

Financial data is updated regularly. All figures are in the company's reporting currency.